Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Pandha, H., Elsheik, S., Hadjimichael, E., Villasanti, N., Adams, S. E., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I., Gijon, M., Hannaman, D. and Durrant, L. G. (2018) Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. OncoImmunology. 7(6) 2162-4011.
10131:30779
Patel_etal_TFO_2018_Targeting_gp100_and_TRP_2_with_a_DNA_vaccine_Incorporating_T_cell_epitopes_with_a_human_IgG1_antibody_induces_potent_T_cell_responses_that_are_associated_with_favourable_clinical_outcome_in_a_phase_I_II_trial
Patel_etal_TFO_2018_Targeting_gp100_and_TRP_2_with_a_DNA_vaccine_Incorporating_T_cell_epitopes_with_a_human_IgG1_antibody_induces_potent_T_cell_responses_that_are_associated_with_favourable_clinical_outcome_in_a_phase_I_II_trial.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Patel_etal_TFO_2018_Targeting_gp100_and_TRP_2_with_a_DNA_vaccine_Incorporating_T_cell_epitopes_with_a_human_IgG1_antibody_induces_potent_T_cell_responses_that_are_associated_with_favourable_clinical_outcome_in_a_phase_I_II_trial.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Information
![]() |